BPC-157 is one of the most extensively studied peptides in preclinical tissue repair research, with published data spanning tendon, muscle, bone, gastrointestinal, and neurological healing models
DOI:10.1007/s13277-013-1030-6 [ Links ] 53
HUBERMAN: So I'm certainly not being disparaging of people that decide to make the choice to take these compounds
Yes, it is often combined with peptides such as BPC-157 or TB-500 in studies aimed at intensive soft tissue and joint recovery
It ensures that your results are a true reflection of the peptide's biological activity, not an artifact of its chemical degradation
Additionally, evaluating how these therapies interact with current antidiabetic treatments and determining their suitability for combination therapies may further enhance their clinical value